RxDoctor Payments Data

Sarabjit Sandhu, MD

Psychiatry · Newport Beach, CANPI 1144287186

Payments from drug & device makers

$2,394in general payments, 2019–2025

Across 165 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sunovion Pharmaceuticals Inc.$701
  • Lundbeck LLC$133
  • Takeda Pharmaceuticals U.S.A., Inc.$96
  • Johnson & Johnson$45
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$44
  • plus $146 from 8 others

What the payments were for

  • Food & beverage$2,394100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,394 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$200,456
Medicare patients
188
Services billed
2,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate235$829,461
AristadaAripiprazole Lauroxil53$173,447
VraylarCariprazine Hcl111$112,494
PerserisRisperidone31$82,878
Lurasidone Hcl411$80,481
Clozapine OdtClozapine101$72,128
Quetiapine Fumarate ErQuetiapine Fumarate684$62,611
XifaxanRifaximin29$45,457
Divalproex Sodium ErDivalproex Sodium624$43,329
IngrezzaValbenazine Tosylate15$41,422
Clozapine386$40,343
CaplytaLumateperone Tosylate35$29,456
RexultiBrexpiprazole16$28,644
TrulicityDulaglutide53$27,637
Olanzapine614$26,799

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Xarelto$45$836,302259 claims
AbbVieVraylar$1,228$112,494111 claims
Indivior Inc.Perseris$22$82,87831 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$96$33,018103 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$44$29,45635 claims
Otsuka America Pharmaceutical, Inc.Rexulti$14$28,64416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →